Showing results (1891-1900 of 2,107) with videos related to
Sort By:
Pageof 211
CNS Drugs|September 11, 2009
Potential influences of complementary therapy on motor and non-motor complications in Parkinson's diseaseTheresa A Zesiewicz, Marian L EvattCNS Drugs|June 10, 2010
Assessment of abuse potential of benzodiazepines from a prescription database using 'doctor shopping' as an indicatorVincent Pradel, Catherine Delga, Frank Rouby, et al.CNS Drugs|September 7, 2006
Buprenorphine-containing treatments: place in the management of opioid addictionSusan E RobinsonCNS Drugs|September 7, 2006
Methylphenidate and its isomers: their role in the treatment of attention-deficit hyperactivity disorder using a transdermal delivery systemDavid J Heal, David M PierceCNS Drugs|September 7, 2006
Rivastigmine: in Parkinson's disease dementiaM Asif A Siddiqui, Antona J WagstaffCNS Drugs|June 21, 2007
Pharmacogenetics and smoking cessation with nicotine replacement therapyRiju Ray, Robert A Schnoll, Caryn LermanCNS Drugs|August 28, 2009
Agomelatine: innovative pharmacological approach in depressionMaurizio PopoliCNS Drugs|July 23, 2009
Issues in the management of patients with complex attention-deficit hyperactivity disorder symptomsThomas J SpencerCNS Drugs|August 20, 2009
The effect of migraine prophylaxis on migraine-related resource use and productivityMiguel J A LáinezCNS Drugs|August 20, 2009
Neuropeptide and sigma receptors as novel therapeutic targets for the pharmacotherapy of depressionKonstantinos A Paschos, Stavroula Veletza, Ekaterini ChatzakiPageof 211